| JYSB2000696 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2021-01-05 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;Roche Diagnostics GmbH;Roche Pharma (Schweiz) Ltd | Certificate Issued | 2021-03-17 | view |
| JYSB2000695 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | In Review | 2022-01-20 | view |
| JYSB2000694 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | In Review | 2022-01-20 | view |
| JYSB2000693 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | In Review | 2022-01-20 | view |
| JYSB2000692 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | In Review | 2022-01-20 | view |
| JYSB2000691 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | In Review | 2022-01-20 | view |
| JYSB2000690 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | In Review | 2022-01-20 | view |
| JYSB2000689 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | In Review | 2022-01-20 | view |
| JYSB2000688 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | In Review | 2022-01-20 | view |
| JYSB2000662 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-12-28 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;Roche Diagnostics GmbH;Roche Pharma (Schweiz) Ltd | In Review | 2020-12-24 | view |
| JYSB2000654 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-12-25 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Roche Pharma (Schweiz) AG | Filed | 2021-01-06 | view |
| JYSB2000653 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-12-25 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;Roche Pharma (Schweiz) AG;F Hoffmann-La Roche Ltd(Switzerland) | Filed | 2021-01-06 | view |
| JYSB2000601 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-12-07 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;Roche Diagnostics GmbH;Roche Pharma (Schweiz) Ltd | Filed | 2020-12-17 | view |
| JYSB2000563 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2020-11-07 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;Roche Diagnostics GmbH;Roche Pharma (Schweiz) Ltd | Filed | 2020-11-20 | view |
| JYSB2000530 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2020-10-26 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;Roche Diagnostics GmbH;Roche Pharma (Schweiz) Ltd | Filed | 2020-11-09 | view |
| JYSB2000426 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-09-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Roche Pharma (Schweiz) AG | Filed | 2020-09-11 | view |
| JYSB2000425 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-09-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Roche Pharma (Schweiz) AG | Filed | 2020-09-11 | view |
| JYSB2000414 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2020-08-21 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Filed | 2020-09-02 | view |
| JYSB2000413 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2020-08-21 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Filed | 2020-09-02 | view |
| JYSB2000412 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2020-08-21 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Filed | 2020-09-02 | view |
